Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neuroimmunology"
DOI: 10.1016/j.jneuroim.2020.577168
Abstract: We aimed in this study to elucidate the impact of serum AQP4-IgG titer before starting treatments to the clinical manifestation of neuromyelitis optica spectrum disorders (NMOSD). Serum titer at the onset, measured using live cell-based… read more here.
Keywords: spectrum disorders; neuromyelitis optica; first attack; optica spectrum ... See more keywords